We are live on ! Find out more
EQOS

EQONEX LIMITED Ordinary Shares
EQOS

Delisted

EQOS was delisted on the 29th of November, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in EQONEX LIMITED Ordinary Shares in 2023 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $642 → $0 (-$642)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
–
Holders Change
-1
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$642
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
– -$642 -23,854 Closed

EQOS Hedge Fund Activity: Q1 2023 in Review

0 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in EQONEX LIMITED Ordinary Shares (EQOS) for Q1 2023, worth a combined $0 — down 100% from $642 a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of EQOS and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Sabby Management, exiting entirely with an estimated $642 sold.

  • 0 institutional investors held EQONEX LIMITED Ordinary Shares (EQOS) as of Q1 2023, down from 1 in Q4 2022.
  • Funds reported $0 of EQONEX LIMITED Ordinary Shares stock for Q1 2023, down 100% quarter-over-quarter.
  • 0 funds opened new EQONEX LIMITED Ordinary Shares positions in Q1 2023 and 1 closed out, a net change of -1 holder.
  • The largest EQONEX LIMITED Ordinary Shares seller in Q1 2023 was Sabby Management, an estimated $642 sold.

Based on aggregated 13F filings for Q1 2023.